Published on : Oct 27, 2017
Albany, New York, October 27, 2017: Artificial intelligence has been increasingly used in many disparate fields including robotics, finance, and air traffic control. But one of the most auspicious uses of AI is in medicine. To quickly and accurately diagnose a patient, there is a critical need in employing computerized technologies to assist in diagnosis and access the related information. The application of artificial intelligence has been reported in the field of medical diagnosis in recent years. Recently, Market Research Hub (MRH) has broadcasted a new study to its mega-repository, which is titled as “Pancreatic Cancer Diagnostics Using Artificial Intelligence for Hospitals: Market Shares, Strategies, and Forecasts, Worldwide, 2017 to 2023”. The study entirely focuses on the worldwide market of pancreatic cancer diagnostics, analyzing its trends, understanding market dynamics and forecasting its future growth from 2017 to 2023. According to the findings, worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and lowering care delivery costs.
Pancreatic Cancer is malignant growth or tumor, which forms due to an uncontrolled division of cells in the pancreas, hence, may even lead to death if not detected at the early stage. It is now the third-most-common cause of cancer death in the U.S. It has been analyzed that with less than five-year survival, the pancreatic cancer market has the highest unmet therapeutic needs in the overall oncology market. Apart from several treatment methods, technologies for the timely diagnosis of this cancer type are developing, which results in a majority of pancreatic cancer patients being diagnosed at an advanced stage of the disease. In the present time, automated cancer diagnostics are implemented with artificial intelligence. The analysis of patient records, looking for the effectiveness of particular treatments is more work than a human can do, the quantity of data is too high, so the artificial intelligence is being used to do that.
AI systems are already being used both to diagnose cancer and to develop new treatments. As per the research, much of the hospital artificial intelligence market is centered on improving diagnosis and treatment of cancer through the visualization provided by radiology. Looking to the wide acceptance of AI systems in cancer diagnostics, analysts forecast that AI is set to become a sophisticated diagnostic aid, flagging images that humans should examine more closely. The study also evaluates that Hospital artificial intelligence market shipments at $1.7 billion in 2016 are forecast to reach $11.4 billion dollars, worldwide 2023.
Moreover, a thorough and insightful analysis of the key companies operating in the global pancreatic cancer diagnostics using artificial intelligence for hospitals market has been offered to the readers. At present, market leaders include IBM and General Electric. Other market participants and companies include Prognos, Alphabet / Google, Zebra, GlaxoSmithKline (GSK), Merck, Quest Diagnostics
Safeguard Scientifics, Berg, TwoXAR, Numerate. Founded in 2006, Berg is using a mix of data analytics software and in-the-lab drug development to find new treatments for devastating diseases like cancer. Also, company wants to cure pancreatic cancer using AI.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1354708
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org